BioSpace News Archive

Capricor Therapeutics, a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of a broad spectrum of diseases, announced that the Company will present final data from its HOPE-2 clinical trial with asset CAP-1002 at this year’s World Muscle Society Virtual Congress.

Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions, announced that Craig Thompson, President and Chief Executive Officer, will present at the Wells Fargo Virtual Healthcare Conference and participate in one-on-one meetings with investors.

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), today announced that Pascal Touchon, President and Chief Executive Officer, will participate in a panel discussion titled, “Autologous, Allogeneic CAR-T, CAR-NK & More - Exploring the State of Play in Cell Therapy,” at the Citi 16th Annual BioPharma Virtual Conference

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), today announced that the Company will participate in Wells Fargo’s Virtual Healthcare Conference and H.C. Wainwright’s 23rd Annual Global Investment Conference.

Emmaus Life Sciences, Inc. (OTC: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced financial results for the six months ended June 30, 2021.

Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Novan management will host a corporate update conference call with live audio webcast on Thursday, September 9, 2021 at 8:30 a.m. ET.

ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on Thursday, September 9, 2021, beginning at approximately 1:15 p.m. (Eastern Daylight Time) via video webcast.

Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products for premature and critically ill infants, will host a panel session on human milk safety at the virtual 2021 National Coalition for Infant Health Summit (NCfIH) on September 2, 2021, at 2:05 p.m. ET.

Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence (“A.I.”) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced the addition of two senior industry executives to support the Company’s clinical and manufacturing initiatives.

Today the Society for Clinical Research Sites (SCRS), the global trade organization dedicated to representing the interests of clinical research sites, has announced Alex Azar, former Secretary of the U.S. Department of Health and Human Services (HHS), as the keynote speaker for its 16th Annual Global Site Solutions Summit.